Mechanisms of sickness-induced decreases in food-motivated behavior

[1]  C. Franceschi,et al.  Invertebrate and Vertebrate Immune Cells Express Pro-opiomelanocortin (POMC) mRNA , 1995, Brain, Behavior, and Immunity.

[2]  R. Dantzer,et al.  Reduction in food and water intake induced by microinjection of interleukin-1β in the ventromedial hypothalamus of the rat , 1994, Physiology & Behavior.

[3]  R. Dantzer,et al.  Expression of type I and type II interleukin-1 receptors in mouse brain. , 1994, Brain research. Molecular brain research.

[4]  R. Dantzer,et al.  Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. , 1994, Brain research. Molecular brain research.

[5]  R. Dantzer,et al.  Central nervous system control of sickness behavior , 1994 .

[6]  R. Dantzer,et al.  A behaviorally active dose of lipopolysaccharide increases sensory neuropeptides levels in mouse spinal cord , 1994, Neuroscience Letters.

[7]  B. D. Clark,et al.  Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. , 1993, Endocrinology.

[8]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[9]  M. Brouns,et al.  Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? , 1992, Brain Research.

[10]  E. Wada,et al.  In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  D. Dripps,et al.  Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. , 1991, The Journal of biological chemistry.

[12]  K. Huebner,et al.  A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. , 1991, The EMBO journal.

[13]  C. Dinarello.  Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.

[14]  K. McIntyre,et al.  Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody , 1991, The Journal of experimental medicine.

[15]  Kobayashi Isao,et al.  Central administration of ibuprofen failed to block the anorexia induced by interleukin-1. , 1991, European journal of pharmacology.

[16]  R. Dantzer,et al.  Behavioural effects of peripherally injected interleukin-1: role of prostaglandins , 1991, Brain Research.

[17]  Toshinori Mori,et al.  Actions of interferonα and interleukin-1β on the glucose-responsive neurons in the ventromedial hypothalamus , 1990, Brain Research Bulletin.

[18]  M. T. Brewer,et al.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.

[19]  Robert C. Thompson,et al.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor , 1990, Nature.

[20]  W. Banks,et al.  Bidirectional transport of interleukin-1 alpha across the blood-brain barrier , 1989, Brain Research Bulletin.

[21]  N. Mrosovsky,et al.  Anorexic effects of interleukin 1 in the rat. , 1989, The American journal of physiology.

[22]  R. Dantzer,et al.  CRF is not involved in the behavioral effects of peripherally injected interleukin 1 in the rat , 1989 .

[23]  S. Zuckerman,et al.  Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis , 1989, European journal of immunology.

[24]  Y. Oomura.  Chemical and neuronal control of feeding motivation , 1988, Physiology & Behavior.

[25]  C. March,et al.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. , 1988, Science.

[26]  B. Hart.  Biological basis of the behavior of sick animals , 1988, Neuroscience & Biobehavioral Reviews.

[27]  C. Plata-salamán,et al.  Tumor necrosis factor and interleukin-1β: suppression of food intake by direct action in the central nervous system , 1988, Brain Research.

[28]  A. Vander,et al.  Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted rats , 1986, Physiology & Behavior.

[29]  V. F. Gellert,et al.  A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. , 1977, The Journal of pharmacology and experimental therapeutics.

[30]  M. Babbini,et al.  Changes in operant behavior as an index of a withdrawal state from morphine in rats , 1972 .

[31]  R. Dantzer,et al.  Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[32]  R. Dantzer,et al.  Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.

[33]  A. Arimura,et al.  Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. , 1990, The American journal of physiology.